Cartesian Therapeutics, Inc.: accounts_receivable
| Value | {"amount": 5870000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | Cartesian Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:22:04.120658+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dc526a20-3353-473b-af2e-191927d1b3cb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001453687-24-000036Retrieved: 2026-08-19T14:22:04.120658+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001453687/accounts-receivable/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dc526a20-3353-473b-af2e-191927d1b3cb
History
- no predecessors — first report